| Record ID | marc_columbia/Columbia-extract-20221130-012.mrc:206563867:2052 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-012.mrc:206563867:2052?format=raw |
LEADER: 02052cam a2200481 a 4500
001 5952613
005 20221121214328.0
008 061012t20072007nyua b 001 0 eng
010 $a 2006922553
016 7 $a101466504$2DNLM
020 $a9780387303444 (alk. paper)
020 $a0387303448 (alk. paper)
029 0 $aNLM$b101466504
035 $a(OCoLC)ocn144519685
035 $a(NNC)5952613
035 $a(OCoLC)144519685
035 $a5952613
040 $aNLM$cNLM$dBTCTA$dBAKER$dYDXCP$dUOH$dCUS
042 $anlmcopyc
050 4 $aRC365$b.H36 2007
060 00 $a2008 C-084
060 10 $aWL 359$bH2356 2007
245 00 $aHandbook of neurochemistry and molecular neurobiology.$pDegenerative diseases of the nervous system /$cvolume editors, Moussa B. H. Youdim [and others].
246 30 $aDegenerative diseases of the nervous system
250 $a3rd ed.
260 $aNew York :$bSpringer,$c[2007], ©2007.
300 $axi, 432 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aSpringer reference
504 $aIncludes bibliographical references and index.
650 12 $aNeurodegenerative Diseases.$0https://id.nlm.nih.gov/mesh/D019636
650 12 $aParkinson Disease.$0https://id.nlm.nih.gov/mesh/D010300
650 0 $aNervous system$xDegeneration.$0http://id.loc.gov/authorities/subjects/sh85090923
650 0 $aNervous system$xDegeneration$xMolecular aspects.
650 0 $aNeuropharmacology.$0http://id.loc.gov/authorities/subjects/sh85091157
650 0 $aNeurochemistry.$0http://id.loc.gov/authorities/subjects/sh85091116
650 0 $aNeuroprotective agents$xTherapeutic use.
650 0 $aParkinson's disease$xPathophysiology.
650 0 $aParkinson's disease$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh85098116
700 1 $aYoudim, Moussa B. H.$0http://id.loc.gov/authorities/names/n80156169
830 0 $aSpringer reference.$0http://id.loc.gov/authorities/names/no2007021123
852 00 $boff,bio$hRC365$i.H36 2007g